REGENERON PHARMACEUTICALS, INC. REGN
출처: SEC EDGAR XBRL companyconcept (10-K) · 통화 USD
검증 ✓ 매출·재무 = SEC EDGAR XBRL companyconcept (10-K) 공시원본 (AI 추정 0) ✓ 재무 신호 = 공시 숫자 계산 (AI 아님)
$4.3B$8.7B$13B$17.4B $16.1B 20082025
🏭 사업부 흥망 해부도(성장·고전·철수·실패) 펼쳐보기 →
재무 신호 · 공시 숫자 계산 · AI 아님 · 판정 없음
✦ 흥망사
버튼을 누르면 위 공시 숫자에 근거한 흥망사를 생성합니다 — AI 서술, 예측·투자조언 없음.
▾ 데이터 표 보기
연도 매출영업이익순이익자산부채 FCF 영업이익률 매출 YoY
2008 $238M-$86M-$79M -36.2%
2009 $379M-$74M-$68M$741M$344M -19.5% ▲ 59.1%
2010 $459M-$97M-$104M$1.1B$562M -21.2% ▲ 21.0%
2011 $446M-$205M-$222M$1.3B$838M -46.0% ▼ 2.9%
2012 $1.4B$458M$750M$2.1B$835M 33.2% ▲ 209.2%
2013 $2.1B$743M$414M$3B$999M 35.3% ▲ 52.7%
2014 $2.8B$824M$338M$3.8B$1.3B 29.2% ▲ 34.0%
2015 $4.1B$1.3B$636M$5.6B$2B 30.5% ▲ 45.5%
2016 $4.9B$1.3B$896M$7B$2.5B 27.4% ▲ 18.4%
2017 $5.9B$2.1B$1.2B$8.8B$2.6B 35.4% ▲ 20.8%
2018 $5.1B$2.5B$2.4B$11.7B$3B 49.3% ▼ 12.4%
2019 $6.6B$2.2B$2.1B$14.8B$3.7B 33.7% ▲ 27.4%
2020 $8.5B$3.6B$3.5B$17.2B$6.1B 42.1% ▲ 29.6%
2021 $16.1B$8.9B$8.1B$25.4B$6.7B 55.7% ▲ 89.1%
2022 $12.2B$4.7B$4.3B$29.2B$6.6B 38.9% ▼ 24.3%
2023 $13.1B$4B$4B$33.1B$7.1B 30.9% ▲ 7.8%
2024 $14.2B$4B$4.4B$37.8B$8.4B 28.1% ▲ 8.3%
2025 $14.3B$3.6B$4.5B$40.6B$9.3B 24.9% ▲ 1.0%